Inno Fire Awards honoree: SweetBio and co-founder Kayla Rodriguez Graff


SweetBio gained U.S. Food and Drug Administration (FDA) clearance in 2019. And since then, it’s continued to gain momentum while weathering the challenges that came with the COVID-19 pandemic.

Previous Houston biotech firm Coya Therapeutics files for IPO
Next Fort Worth-based agricultural lending and crop insurance provider names new CEO